We invite you to join us for an informational presentation about the latest advances in treatment options for uterine fibroids.
Learn More(opens in a new tab)
Are uterine fibroids causing you:
It doesn’t have to be this way!
The Sonata Treatment is an incisionless treatment option for women with symptomatic uterine fibroids. It is an outpatient procedure in the United States. The technical term for the procedure is Transcervical Fibroid Ablation.
Many women return to normal activity the next day.
The fibroids are treated from inside the uterus, so there’s no cutting or scarring.
Unlike a hysterectomy, treatment with the Sonata system does not eliminate the possibility of pregnancy.
At the Advanced Women’s Health Institute, we’re committed to providing you with the least-invasive options available, including the Sonata treatment for fibroid tumors. We’ll listen and work with you to develop a personalized treatment plan that works for you.
If you need relief from fibroids, schedule an appointment with us today, or see if you’re eligible for our Sonata Treatment Study:
AppointmentsSonata Treatment Study
With the Sonata Treatment, the fibroids are treated from inside the uterus, so there's no incision. Many women return to normal activity the next day. Watch this video to learn more about the Sonata Fibroid Treatment.
Uterine fibroids are non-cancerous (benign) growths in or around the uterus. The vast majority of women in the United States will have fibroids by the age of 50.
ACOG recommends treating fibroids as benign. The incidence of cancer in fibroid tumors is low (1/1000 cases) in premenopausal women. Neither rapid growth nor degeneration can predict cancer before surgery. If you're not experiencing significant issues and your fibroids are small, it's okay to wait before intervening.
Around 30-50% of women may develop new fibroids within five years after surgery and some may require a second operation. Recurrence is more common in younger women and those who had more than 3 fibroids during their first operation.
The Sonata System is intended for diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, including those associated with heavy menstrual bleeding.
Common Side Effects include bleeding, spotting, cramping, post-ablation inflammatory symptoms, and/or discharge. Potential Risks include bowel or bladder injury; hematometrium; hemorrhage; infection; retention of device fragment; skin burn; thrombotic events; unintended injury to the uterus, cervix or vaginal vault, adjacent organs or tissue; unknown risk to future pregnancies; and complications including death.
Safety and effectiveness with regard to fertility and fecundity after use of the Sonata System have not been established. As a uterus-conserving alternative to hysterectomy, treatment with the Sonata System does not eliminate the possibility of pregnancy.